Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.
about
Canadian practice guidelines for surgical intra-abdominal infectionsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study.Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use.Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004Longitudinal surveillance of outpatient quinolone antimicrobial use in Canada.Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015.Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistancePopulation mobility, globalization, and antimicrobial drug resistance.Barriers to intravenous penicillin use for treatment of nonmeningitis pneumococcal disease.Management of febrile neutropenia in the era of bacterial resistanceUsing interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusClinical importance and epidemiology of quinolone resistance.In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesRegional variation in antibiotic prescribing among medicare part D enrollees, 2013Implementation of an antimicrobial stewardship program on the medical-surgical service of a 100-bed community hospital.Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistanceEpidemiology of staphylococcal resistance.Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.Association between antimicrobial consumption and resistance in Escherichia coli.Diversity of antimicrobial use and resistance in 42 hospitals in the United States.Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia.Antibiotic use and population ecology: how you can reduce your "resistance footprint".Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.The challenge of methicillin-resistant Staphylococcus aureus prevention in hemodialysis therapy.Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistanceOptimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence.Antibiotically active metabolites from Talaromyces wortmannii, an endophyte of Aloe vera.Exploring the correlations between antibiotics and antibiotic resistance genes in the wastewater treatment plants of hospitals in Xinjiang, China.Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium.Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System.Staphylococcus aureus strains isolated from bloodstream infections changed significantly in 2006The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settingsDifferential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection.
P2860
Q24599288-D9EE4721-9917-4742-B0DE-7AD8E96E0BEBQ28388806-2A98169D-5BCF-49CA-AE14-723EEB7513E9Q30238945-C34FCE83-620B-4384-B95E-E30473FE15BCQ30978227-51A7771B-02B2-47A2-B89E-72765966A50BQ31019263-6B0CF4F2-6C9D-4AD4-ABA8-82EBA4EB106DQ31087017-7331C143-D4DB-4E13-BC8F-1FC95A950217Q33640223-ABC9D5F4-FAB2-4283-800F-C203AD32E3E7Q33698908-9CF07675-2306-45E8-AD0C-DB84DBFF8E4CQ33749940-A83CAEB4-8548-41A4-B3C9-8D5C42678066Q33800616-384440FD-B6DE-481E-A827-C3FAFBA0CED8Q34120415-C1C9403C-8D54-4DAB-919C-901329640F2CQ34664160-788FC2E6-892F-432F-B40A-207CBB357971Q34680578-86BBF0F0-BC06-43B5-B3A1-17060CAD0918Q34838791-F48A87E3-D178-43F6-A3ED-E0C5A0225F89Q35867468-2D766325-D6D0-40AF-8851-E6F7B057024CQ35986250-D3A476E3-A552-4AFC-9F1C-F6F5E238048BQ36219079-B30603EF-DEB1-414C-8BDA-B3B04261C21EQ36402314-B08F90BD-542A-44A1-B24B-81CEBA3DA7D8Q36595082-48E42BDB-1F90-4A3D-A714-F639525932C7Q36757737-CE2603F7-7960-4DF4-896B-62507389C981Q36916068-F8937ABB-2872-460F-8054-8B730E3CC81CQ37079106-F50EAA75-74CE-46DF-BF84-63BDE452D99FQ37115726-39EA23D1-45BB-44B7-B841-B88835F5990AQ37199197-8D5D8CCD-9F04-4CCF-87AD-0305B3BE1B7DQ37217108-98AAE518-F221-481C-82DC-E0434B93072EQ37338130-4B26A81E-2E5B-490D-9DF0-1D0BDB2F7202Q37394508-AEE40202-51AD-42E4-9BC1-80826F638051Q37461442-9BDC25C4-219A-4906-8C90-1A7C9FF1054DQ37811699-30BA41DE-4955-41FB-B77B-A98A8D73567AQ37965848-15CF2777-0971-47FA-8DA6-40EFD02987A8Q38512609-8E50AD62-713C-4141-97C6-3C56D0C4A095Q38751083-091EB11E-15D7-4F98-818C-7A7561215519Q38892109-1E5E5BC4-FB2D-4650-BF03-27E3205BE397Q39839031-98BE12C3-CE86-4CD3-9F81-E6C4F73CBFC6Q40267696-61EBA5D3-24EA-4F6F-BD84-0267518B0B3FQ40432811-39DE1529-C0BF-47A9-B1BE-80CE93DFF1F0Q41999265-F420F711-8770-4BE4-9F32-852A541010F3Q42232753-FD858975-12DB-4385-B7B4-9896F99C487AQ44654345-469556CA-7B57-4864-971F-367ACFB112B2Q44663435-B12BD190-2B38-42F0-89F0-8043E7F0B797
P2860
Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@en
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@nl
type
label
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@en
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@nl
prefLabel
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@en
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@nl
P2093
P2860
P356
P1476
Hospital and community fluoroq ...... ichia coli in 17 US hospitals.
@en
P2093
Christopher K Johnson
Conan MacDougall
J Patrick Powell
Ronald E Polk
P2860
P304
P356
10.1086/432056
P407
P577
2005-06-28T00:00:00Z